z-logo
Premium
Involvement of 5‐HT 1B/1D and 5‐HT 2A receptors in 5‐HT‐induced contraction of endothelium‐denuded rabbit epicardial coronary arteries
Author(s) -
Ellwood Amanda J.,
Curtis Michael J.
Publication year - 1997
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0701470
Subject(s) - 5 ht receptor , serotonin , contraction (grammar) , receptor , endothelium , medicine , chemistry , endocrinology
1 The receptors responsible for 5‐hydroxytryptamine (5‐HT)‐mediated contraction of rabbit isolated epicardial coronary artery denuded of endothelium was examined by bioassay. 2 A variety of 5‐HT mimetics caused concentration‐dependent contractions. The rank order of agonist potency was 5‐carboxamidotryptamine (5‐CT)>5‐HT>(±)‐α‐methyl‐5‐hydroxytryptamine ((±)‐α‐me‐5‐HT)=sumatriptan. This was not consistent with relative potencies at any single recognized 5‐HT receptor, suggesting the presence of a mixed receptor population. In one subset of preparations precontracted with U46619 (10–30 n M ) with the endothelium intact, none of the agonists caused a relaxation. 3 Contractions to 5‐HT were antagonized by ketanserin, a 5‐HT 2A ‐selective antagonist, but the displacement of concentration‐response curves was inconsistent with an interaction between 5‐HT and a single receptor population; the slope of regression between antagonist log M concentration and agonist log (concentration‐ratio −1) was shallow (0.57). Responses to 5‐HT were also antagonized by the 5‐HT 1B/1D ‐receptor antagonist GR127935 and, again, the slope of regression was shallow (0.68). These data suggest a possible involvement of 5‐HT 2A and 5‐HT 1B or 5‐HT 1D receptors in the response to 5‐HT. 4 Contractions to (±)‐α‐me‐5‐HT, which is selective for 5‐HT 2A over 5‐HT 1B and 5‐HT 1D receptors, were competitively antagonized by low concentrations of ketanserin. The regression between antagonist log  M concentration and agonist log (concentration‐ratio −1) fitted the Schild equation with a slope that was not significantly different from unity (0.95), giving a pA 2 value of 9.0. GR127935 (3–30 n M ), had no effect on the contractile response to (±)‐α‐me‐5‐HT. These data establish, unequivocally, the presence of 5‐HT 2A receptors in the tissue. 5 Sumatriptan, a relatively selective 5‐HT 1B/1D ‐receptor agonist, induced contractions that were antagonized competitively by GR127935 (3–30 n M ), although there was a reduction in the maximum response when concentrations of GR127935 exceeded 3 n M . The apparent pA 2 (estimated by imposing a unit slope on the log agonist (concentration‐ratio −1) value in the presence of 3 n M GR127935) was 8.92. Contractions to sumatriptan were not affected by low (5‐HT 2A receptor‐selective) concentrations of ketanserin, but were antagonized in a competitive manner at higher concentrations (pA 2 6.5). These data appear to confirm the presence of 5‐HT 1B and/or 5‐HT 1D receptors in the tissue. 6 Antagonism of 5‐HT responses by GR127935 was reassessed after blockade of 5‐HT 2A receptors with 1 μ M ketanserin. Under these conditions, GR127935 was able to antagonize 5‐HT‐induced contractions fully. The slope of regression between log M antagonist concentration and log agonist (concentration‐ratio −1) fitted the Schild equation with a slope not significantly different from unity (1.1) (albeit there was still a reduction in maximum response when GR127935 concentration exceeded 3 n M ). The apparent pA 2 value was 8.8. This reinforces the evidence that 5‐HT 1B and/or 5‐HT 1D receptors contribute to the effects of 5‐HT in the tissue. 7 In conclusion, in endothelium denuded rabbit epicardial coronary arteries, 5‐HT activates 5‐HT 2A and 5‐HT 1D and/or 5‐HT 1B receptors to cause contraction. This appears to be similar to the situation in man.British Journal of Pharmacology (1997) 122 , 875–884; doi: 10.1038/sj.bjp.0701470

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom